AZBio

AZBio is a news site that focuses on the biotechnology and pharmaceutical industries in Arizona. It covers topics such as research advancements, partnerships, and regulatory updates. The site features success stories from Arizona's bioindustry and provides information about events and initiatives related to the industry.

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This news site is known for its high journalistic standards. It strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. It has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

  • Elon Musk's Neuralink Chooses Arizona Institute for Groundbreaking Brain-Computer Interface Study with First Participant Noah Arbaugh

    Elon Musk's Neuralink Chooses Arizona Institute for Groundbreaking Brain-Computer Interface Study with First Participant Noah Arbaugh

    Broke On: Thursday, 18 April 2024 Elon Musk's Neuralink, a brain-implant company, began its Telepathy device study at Barrow Neurological Institute in Phoenix with the first participant, Noah Arbaugh, undergoing a successful procedure. The goal is to enable paralyzed individuals to use computers with their thoughts. Criticized for lack of peer-reviewed research and transparency, the trial evaluates safety and effectiveness of the device on adults with quadriplegia or ALS.